Healthcare Global Enterprises Limited (HCG), India's largest provider of cancer care, has announced two significant strategic decisions aimed at strengthening its presence in the African healthcare market. The company's Board of Directors has approved an investment in its Kenyan subsidiary and a financial guarantee to support its expansion plans.

Investment in Cancer Care Kenya Limited

HCG's board has given the green light for acquiring up to 10% of the shares in Cancer Care Kenya Limited (CCK), a step-down subsidiary of the company. The investment, valued at up to INR 7.00 crore, is expected to be completed by March 31, 2026. This move underscores HCG's commitment to expanding its oncology services in the East African region.

CCK operates a comprehensive cancer hospital in Nairobi, offering radiation and chemotherapy services, including a 15-bed Day Care Centre. The subsidiary has shown remarkable growth, with its revenue surging from INR 9.07 crore to INR 42.53 crore. Moreover, CCK reported a profit after tax of INR 10.83 crore, highlighting its strong financial performance.

Financial Guarantee for Business Expansion

In addition to the equity investment, HCG's board has approved the issuance of a Standby Letter of Credit (SBLC) to secure a USD 1.8 million (approximately INR 16.00 crore) term loan for CCK. This financial backing is intended to support CCK's business expansion plans in Kenya.

The company's potential liability under this guarantee is capped at 105% of CCK's outstanding loan amount. HCG will treat this guarantee as a contingent liability on its balance sheet.

Strategic Implications

These decisions reflect HCG's strategic focus on strengthening its international presence, particularly in the African healthcare market. By increasing its stake in CCK and providing financial support for expansion, HCG aims to capitalize on the growing demand for specialized cancer care services in Kenya and potentially the broader East African region.

Dr. B.S. Ajaikumar, Executive Chairman of HCG, stated, "Our investment in Cancer Care Kenya Limited aligns with our vision of bringing advanced cancer care to more patients across borders. We see significant potential in the Kenyan market and are committed to supporting CCK's growth and expansion plans."

The move is expected to not only enhance HCG's global footprint but also contribute to improving cancer care infrastructure in Kenya, potentially setting the stage for further expansion in the African continent.

As HCG continues to execute its growth strategy, investors and industry observers will be keenly watching how these international investments impact the company's overall financial performance and market position in the coming years.

Healthcare Global Enterprises Limited (HCG), a leading provider of comprehensive cancer care in India, has announced the appointment of Manu Shankar Das as its new Chief Marketing Officer. The decision was approved by the company's Board of Directors on November 12, 2025, based on the recommendation of the Nomination and Remuneration Committee.

Appointment Details

Das is expected to join HCG on or before December 20, 2025, and will be part of the company's Senior Management Personnel. This strategic appointment comes as HCG continues to strengthen its leadership team and enhance its marketing capabilities.

Extensive Experience

Manu Shankar Das brings over 15 years of cross-industry marketing experience to his new role at HCG. His diverse background spans several sectors, including:

• Healthcare
• Interior Design
• Food & Hospitality
• Travel
• FMCG (Fast-Moving Consumer Goods)
• Information Technology

Areas of Expertise

Das's expertise covers a wide range of marketing disciplines, including:

• Performance marketing
• Brand strategy
• Product marketing
• Digital marketing
• Sales promotions

Professional Background

Prior to joining HCG, Das has held positions at several notable organizations:

• MediBuddy
• Rebbus
• Bonito Designs
• Flavors Unlimited

Additionally, Das has a background as a software engineer, with more than 12 years dedicated to marketing and branding roles.

Strategic Importance

The appointment of Manu Shankar Das as Chief Marketing Officer is expected to bolster HCG's marketing strategies and brand presence in the competitive healthcare sector. His diverse experience across multiple industries may bring fresh perspectives to HCG's marketing initiatives, potentially helping the company to expand its reach and strengthen its position as a leader in cancer care.

As HCG continues to grow its network of comprehensive cancer centers across India and Africa, Das's expertise in performance marketing and digital strategies could play a crucial role in enhancing the company's patient outreach and engagement efforts.

The healthcare industry, particularly in specialized fields like oncology, requires nuanced marketing approaches. Das's background in both healthcare and technology sectors positions him well to navigate the complexities of marketing advanced medical services while maintaining sensitivity to patient needs.

HCG's decision to bring in a marketing professional with such diverse experience signals the company's commitment to innovative marketing strategies in the evolving healthcare landscape. As the new Chief Marketing Officer, Manu Shankar Das will likely be tasked with elevating HCG's brand, driving patient engagement, and supporting the company's mission to make advanced cancer care accessible to a wider population.